The BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Activity, and Microglial Activation of Nasal Foralumab

NCT07688239 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

ALS (Amyotrophic Lateral Sclerosis)
ALS - Amyotrophic Lateral Sclerosis
ALS

Interventions

DRUG: Foralumab Nasal
DRUG: Placebo

Sponsor

Tiziana Life Sciences LTD